Lactulose Breath Testing Predicts Response to Rifaximin for Cardinal Irritable Bowel Syndrome With Diarrhea (IBS-D)

被引：0
|
作者：
Rezaie, Ali [1 ]
Heimanson, Zeev [2 ]
Israel, Robert J. [2 ]
McCallum, Richard [3 ]
Pimentel, Mark [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Salix Pharmaceut, Bridgewater, NJ USA
[3] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
468
引用
收藏
页码：S269 / S269
页数：1
相关论文
共 50 条
  • [1] Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
    Rezaie, Ali
    Heimanson, Zeev
    McCallum, Richard
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (12): : 1886 - 1893
  • [2] Impact of Colonoscopy Timing on Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Lacy, Brian E.
    Lembo, Anthony
    Pimental, Mark
    Heimanson, Zeev
    Cash, Brooks D.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S295 - S295
  • [3] Lack of Utility of Lactulose Breath Testing in the Irritable Bowel Syndrome (IBS)
    Sandhu, Davinder K.
    Talley, Nicholas J.
    Locke, G. Richard
    Zinsmeister, Alan R.
    Sandberg, Rodney
    Saito, Yuri A.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A484 - A484
  • [4] Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D), by Baseline Pain Severity
    Lembo, Anthony
    Heimanson, Zeev
    Cash, Brooks D.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S251 - S251
  • [5] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [6] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [7] CHARACTERIZATION OF ABDOMINAL PAIN RESPONSE TO RIFAXIMIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D), BY BASELINE PAIN SEVERITY
    Lembo, Anthony
    Heimanson, Zeev
    Cash, Brooks D.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S775 - S775
  • [8] RIFAXIMIN IS EFFICACIOUS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS PREVIOUSLY TREATED WITH OTHER IBS MEDICATIONS
    Rao, Satish S.
    Schoenfeld, Philip S.
    Heimanson, Zeev
    Rezaie, Ali
    Lacy, Brian E.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S852 - S852
  • [9] Lactulose Breath Testing and Irritable Bowel Syndrome Response
    Jones, Michael P.
    Bratten, Jason
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (10): : 2653 - 2654
  • [10] Use of Lactulose Breath Tests to Predict Response to Rifaximin in Irritable Bowel Syndrome With Diarrhea: The Positives and Negatives
    Black, Christopher J.
    Ford, Alexander C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (06): : 955 - 956
12345